Monitoring Agency Report for the quarter ended March 31, 2025
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rainbow Childrens Medicare has submitted the Monitoring Agency Report (by HDFC Bank) for Q4 FY25 regarding the use of its April 2022 IPO proceeds. The total issue size was Rs. 15,808.49 million, of which the fresh issue component was Rs. 2,800 million across three stated purposes: early redemption of NCDs to CDC Emerging Markets (Rs. 400 million), capital expenditure for new hospitals and medical equipment (Rs. 1,700 million), and general corporate purposes (Rs. 576.10 million, revised upward by Rs. 14.70 million of unspent IPO expenses). As of March 31, 2025, all Rs. 2,676.10 million of fresh issue proceeds have been fully deployed, with Rs. 116.29 million spent in Q4 FY25 (mainly on medical equipment and hospital fit-outs). HDFC Bank confirmed no deviation from the stated objects and no major deviation from earlier reports. The Audit Committee noted the report on May 13, 2025.
This is a routine regulatory filing confirming complete and compliant deployment of IPO funds with no deviations or delays, which is a neutral-to-slightly-positive signal for investors as it closes the IPO monitoring cycle. Shareholders can take comfort that management used the raised capital as originally promised.